Sign Up Today and Learn More About Kangpu Biopharmaceuticals, Ltd. Stock
Invest in or calculate the value of your shares in Kangpu Biopharmaceuticals, Ltd. or other pre-IPO companies through EquityZen's platform.
Kangpu Biopharmaceuticals, Ltd. Stock (KABL)
Kangpu Bio-Pharma is a clinical stage company.
About Kangpu Biopharmaceuticals, Ltd. Stock
Founded
2011
Industries
Software, Artificial Intelligence, Data and Analytics
Kangpu Biopharmaceuticals, Ltd. Press Mentions
Stay in the know about the latest news on Kangpu Biopharmaceuticals, Ltd.
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024
prnewswire • Jun 25, 2024
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024
biospace • Jun 25, 2024
FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for ...
prnewswire • Jun 25, 2024
FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for ...
morningstar • Jun 25, 2024
Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818 in Crohn's Disease at the 19th Congress ...
prnewswire • Apr 07, 2024
Kangpu Biopharmaceuticals, Ltd. Management
Leadership team at Kangpu Biopharmaceuticals, Ltd.
Chief Business Officer
Fiona Du
Founder, Chairman & Chief Executive Officer
Chuansheng Ge
Join now and verify your accreditation status to gain access to:
- Kangpu Biopharmaceuticals, Ltd. current valuation
- Kangpu Biopharmaceuticals, Ltd. stock price
- Available deals in Kangpu Biopharmaceuticals, Ltd. and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Kangpu Biopharmaceuticals, Ltd. Stock
How to invest in Kangpu Biopharmaceuticals, Ltd. stock?
Accredited investors can buy pre-IPO stock in companies like Kangpu Biopharmaceuticals, Ltd. through EquityZen funds. These investments are made available by existing Kangpu Biopharmaceuticals, Ltd. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kangpu Biopharmaceuticals, Ltd. stock?
Shareholders can sell their Kangpu Biopharmaceuticals, Ltd. stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
